Saylo Construction

Nam augue velit, fermentum sed erat non, efficitur interdum lectus. Donec hendrerit lorem a dui euismod tempus. Vivamus auctor blandit tellus et interdum.

Get In Touch
image
22 Jul

Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement

Read More
image
28 May

Applied DNA Announces Pricing of $12 Million Public Offering

Read More
image
02 May

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock

Read More
image
26 Mar

Laidlaw’s James Ahern Named to Crain’s New York Notable Leaders in Finance 2024

Read More
image
20 Mar

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Read More
image
04 Mar

Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read More
© 2024 Copyright Laidlaw & Company (UK) Ltd. – All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through StoneX, a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).